Media reports suggesting Israel’s Health Ministry is examining a small number of cases of myocarditis in people who had received the Pfizer-BioNTech COVID-19 vaccine
Media reports suggesting Israel’s Health Ministry is examining a small number of cases of myocarditis in people who had received the Pfizer-BioNTech COVID-19 vaccine
This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.
This article has been translated from its original language. Please reach out if you have any feedback on the translation.
There have been reports that Israel’s Health Ministry said on Sunday it is examining a small number of cases of myocarditis (heart inflammation) after receiving the Pfizer-BioNTech COVID-19 vaccine.
There have been reports that Israel’s Health Ministry said on Sunday it is examining a small number of cases of myocarditis (heart inflammation) after receiving the Pfizer-BioNTech COVID-19 vaccine.
Publication
What our experts say
Context and background
Resources
Expert Comments:
Prof Adam Finn
Press reports concerning cases of myocarditis in Israel in the context of their vaccine programme using the Pfizer-BioNTech COVID19 vaccine appear to be both preliminary and inconclusive. This is another example of proof that vaccine safety monitoring systems can work well if they are set up properly – but not proof for the moment whether there is a real problem. Clarity on that can be expected to come reasonably soon, but, in the meantime, we have to accept that when very rare events occur, it is never possible to work out whether they are causally-related to drugs and vaccines straight away. That takes time and careful, systematic investigation. For now it’s just a “wait and see” scenario.
